Cholinergic innervation of the zebrafish olfactory bulb.
A number of fish species receive forebrain cholinergic input but two recent reports failed to find evidence of cholinergic cell bodies or fibers in the olfactory bulbs (OBs) of zebrafish. In the current study we sought to confirm these findings by examining the OBs of adult zebrafish for choline acetyltransferase (ChAT) immunoreactivity. We observed a diffuse network of varicose ChAT-positive fibers associated with the nervus terminalis ganglion innervating the mitral cell/glomerular layer (MC/GL). The highest density of these fibers occurred in the anterior region of the bulb. The cellular targets of this cholinergic input were identified by exposing isolated OBs to acetylcholine receptor (AChR) agonists in the presence of agmatine (AGB), a cationic probe that permeates some active ion channels. Nicotine (50 microM) significantly increased the activity-dependent labeling of mitral cells and juxtaglomerular cells but not of tyrosine hydroxlase-positive dopaminergic neurons (TH(+) cells) compared to control preparations. The nAChR antagonist mecamylamine, an alpha7-nAChR subunit-specific antagonist, calcium-free artificial cerebrospinal fluid, or a cocktail of ionotropic glutamate receptor (iGluR) antagonists each blocked nicotine-stimulated labeling, suggesting that AGB does not enter the labeled neurons through activated nAChRs but rather through activated iGluRs following ACh-stimulated glutamate release. Deafferentation of OBs did not eliminate nicotine-stimulated labeling, suggesting that cholinergic input is primarily acting on bulbar neurons. These findings confirm the presence of a functioning cholinergic system in the zebrafish OB.
Edwards
Jeffrey G
JG
University of Utah School of Medicine, Department of Physiology, Salt Lake City, Utah 84108-1297, USA.
Greig
Ann
A
Sakata
Yoko
Y
Elkin
Dimitry
D
Michel
William C
WC
D000109:Acetylcholine / Q000494:pharmacology; D000376:Agmatine / Q000494:pharmacology; D000818:Animals; D001931:Brain Mapping; D002795:Choline O-Acetyltransferase / Q000378:metabolism*; D004347:Drug Interactions; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D018698:Glutamic Acid / Q000378:metabolism; D008464:Mecamylamine / Q000494:pharmacology; D009474:Neurons / Q000145:classification / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D018733:Nicotinic Antagonists / Q000494:pharmacology; D009830:Olfactory Bulb / Q000166:cytology / Q000201:enzymology*; D009833:Olfactory Pathways / Q000502:physiology*; D010078:Oxazines / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D015027:Zebrafish; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D018691:Excitatory Amino Acid Antagonists; D018733:Nicotinic Antagonists; D010078:Oxazines; C050420:nicotone; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D008464:Mecamylamine; D000376:Agmatine; D014446:Tyrosine 3-Monooxygenase; D002795:Choline O-Acetyltransferase; D000109:Acetylcholine